Haleon plc (HLN)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$9.50
+0.05%
Mkt Cap $45.70B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $7.57B | $7.51B | -0.79% | $0.25 | $0.26 | +3.38% | — | — |
| Q4 2025 Oct 30, 2025 | $2.76B | $7.52B | +171.94% | $0.24 | $0.14 | -42.83% | — | — |
| Q3 2025 Aug 7, 2025 | $2.76B | $7.25B | +162.40% | $0.24 | $0.08 | -67.33% | — | — |
| Q1 2025 Feb 27, 2025 | $2.73B | $7.14B | +161.17% | $25.25 | $0.05 | -99.80% | — | — |
| Q4 2024 Oct 31, 2024 | $11.04B | $6.93B | -37.22% | $0.11 | $0.14 | +27.27% | — | — |
| Q2 2024 May 1, 2024 | $3.70B | $7.21B | +94.93% | $0.11 | $0.12 | +9.09% | — | — |
| Q1 2024 Feb 29, 2024 | $7.03B | $7.04B | +0.05% | $10.27 | $6.54 | -36.32% | — | — |
| Q3 2023 Aug 2, 2023 | $7.06B | $7.28B | +3.05% | $0.22 | $0.08 | -63.50% | — | — |
| Q1 2023 Mar 2, 2023 | $6.80B | $6.78B | -0.27% | $0.23 | $0.21 | -9.70% | — | — |
| Q3 2022 Sep 20, 2022 | $6.41B | $5.92B | -7.59% | $0.22 | $0.22 | -1.57% | — | — |
| Q4 2021 Dec 31, 2021 | — | $3.36B | — | — | $0.11 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $3.19B | — | — | $0.07 | — | — | — |